Cases 51 - 60 of 190
Insys Therapeutics, Inc. et al v. Endo Generics Holdings, Inc. et al
as 1:2017cv05955
Plaintiff:
Insys Therapeutics, Inc. and Insys Development Company, Inc.
Defendant:
Endo Generics Holdings, Inc. and Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Insys Therapeutics, Inc. et al v. Endo Generics Holdings, Inc. et al
as 1:2017cv01078
Plaintiff:
Insys Therapeutics, Inc. and Insys Development Company, Inc.
Defendant:
Endo Generics Holdings, Inc. and Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Hospira, Inc.
as 1:2017cv00944
Plaintiff:
Par Pharmaceutical, Inc. , Par Sterile Products, LLC and Endo Par Innovation Company, LLC
Defendant:
Hospira, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Par Pharmaceutical, Inc.
as 1:2017cv00873
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Par Pharmaceutical, Inc.
as 1:2017cv04984
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Noden Pharma DAC v. Anchen Pharmaceuticals, Inc. et al
as 1:2017cv00728
Plaintiff:
Noden Pharma DAC
Defendant:
Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. PAR PHARMACEUTICAL, INC. et al
as 2:2017cv03159
Plaintiff:
CELGENE CORPORATION
Defendant:
PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICAL COMPANIES, INC., TEVA PHARMACEUTICALS USA, INC. and others
Cause Of Action: 35 U.S.C. § 271
Eli Lilly and Company et al v. Par Pharmaceutical, Inc. et al
as 1:2017cv00456
Plaintiff:
Eli Lilly and Company , Eli Lilly Export S.A. and Acrux DDS Pty Ltd.
Defendant:
Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc.
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY et al v. PAR PHARMACEUTICAL, INC. et al
as 1:2017cv01219
Plaintiff:
ACRUX DDS PTY LTD, ELI LILLY AND COMPANY and ELI LILLY EXPORT S.A.
Defendant:
PAR PHARMACEUTICAL, INC. and PAR PHARMACEUTICALS COMPANIES, INC.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Shire-NPS Pharmaceuticals, Inc. v. Ambio, Inc. et al
as 1:2017cv00397
Plaintiff:
Shire-NPS Pharmaceuticals, Inc.
Defendant:
Ambio, Inc. , AmbioPharm, Inc. , Par Pharmaceutical Companies, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
